{"version":"1.0","type":"link","title":"Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.","author_name":"Kim JS 외","author_url":"https://prs-insight.online/author/Kim%20JS","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/110414","thumbnail_width":1200,"thumbnail_height":630}